Tirzepatide leads to greater and faster weight loss than semaglutide in a real-world analysis of more than 20,000 patients ...

When physicians grapple with anger, it leaches into every part of the day and saps the best parts of your energy and demeanor ...

Aging Baby Boomers have brought cardiology to a critical juncture, fueling demand for minimally invasive procedures and AI ...

A multimodal AI model identified a subset of men with very high-risk localized prostate cancer who derived substantial ...

Ten confirmed cases in Barcelona suggest that a rare skin infection may be spreading through sexual networks, prompting ...

Achieving at least 15% weight loss within 2 years of a T2D diagnosis is linked to lower risks for macrovascular and ...

A hyaluronic acid injectable product previously approved for cheek smoothing gets a new indication for reducing horizontal ...

While osteoarthritis is the most common cause of joint pain, stiffness, and swelling, primary care clinicians should first ...

Experts urge clinicians to address intimacy and sexual well-being routinely, noting that chronic pain often affects ...

High temperatures, humidity, and prolonged exertion can overwhelm the body’s cooling systems. Here’s what clinicians should ...

Sleep apnea isn’t just a middle-aged snoring man disease. Dr Alison Kole explains why soft symptoms often mask severe OSA in women and how to spot them.

A 3-month course of romosozumab followed by denosumab produced bone density gains comparable to those of the standard 12-month regimen in postmenopausal women at high fracture risk.